Search results for "Cancer"

showing 10 items of 11546 documents

The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease

2005

Background. We have recently demonstrated that the presence of Residual Vein Thrombosis (RVT), UltraSonography (US)-detected at the 3rd month after an episode of Deep Vein Thrombosis (DVT) of the lower limbs, is an independent risk factor for developing recurrent Venous Thromboembolism (VTE). The management of DVT patients by detection of RVT may, therefore, represent a simple and reproducible method for establishing the individual risk of recurrence and for tailoring the optimal duration of Oral Anticoagulants (OA) (Siragusa S et al. Blood 2003;102(11):OC183a). At the present, it is unknown whether RVT may also identify patients at increased risk for cancer and/or cardiovascular disease (C…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)Deep veinImmunologyCancerCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyThrombosisSurgeryVenous thrombosismedicine.anatomical_structureInternal medicinemedicinecardiovascular diseasesRisk factorProspective cohort studybusinessSurvival analysis
researchProduct

237 Selected global health assessment tools significantly predict postoperative clinical outcome in elderly patients with ovarian cancer

2021

Introduction/Background* This study evaluated the impact of the global health status on the rate of postoperative clinical complications in patients with ovarian cancer (OC) older than 60 years. Methodology Selected global health status assessment tools were retrospectively determined in a cohort of OC patients older than 60 years, treated at our institution between 2008 and 2019. The primary outcome was the incidence and type of postoperative clinical complications in accordance with the Veteran Affairs’ National Surgical Quality Improvement Program (NSQIP). Differences in binary and ordinal variables between independent groups were analyzed by the chi-square test. Furthermore, rank correl…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.diseaseAcs nsqipStatus assessmentPrimary outcomeInternal medicineCohortmedicineGlobal healthIn patientOvarian cancerbusinessOvarian cancer
researchProduct

Borderline resectable pancreatic cancer. Challenges and controversies.

2018

Abstract Pancreatic cancer is a dismal disease with an increasing incidence. Despite the majority of patients are not candidates for curative surgery, a subgroup of patients classified as borderline resectable pancreatic cancer can be selected in whom a sequential strategy of neoadjuvant therapy followed by surgery can provide better outcomes. Multidisciplinary approach and surgical pancreatic expertise are essential for successfully treating these patients. However, the lack of consensual definitions and therapies make the results of studies very difficult to interpret and hard to be implemented in some settings. In this article, we review the challenges of borderline resectable pancreatic…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentGeneral surgeryGeneral MedicineDisease030230 surgerymedicine.diseasePancreatic Neoplasms03 medical and health sciences0302 clinical medicineOncologyNeoadjuvant treatmentBorderline resectable030220 oncology & carcinogenesisPancreatic cancerPreoperative CaremedicineCurative surgeryHumansRadiology Nuclear Medicine and imagingbusinessNeoadjuvant therapyCancer treatment reviews
researchProduct

Evaluation of the Effectiveness of Breastfeeding as a Factor in the Prevention of Breast Cancer

2020

Background: As cancer is one of the main causes of fatal illnesses in the world, and breast cancer is responsible for an elevated number of deaths in women, it is important to implement measures to prevent this disease. Method: In order to assess the influence of breastfeeding in preventing breast cancer in women, forteen prospective cohort articles are included in this study, and their methodological quality has been assessed through the Newcastle Ottawa quality assessment scale cohort studies. After determining the risk of bias for each case study, those with fewer systematic errors and therefore greater validity, have been selected to demonstrate the relationship they propose exists bet…

medicine.medical_specialtybusiness.industryIncidenceEndocrinology Diabetes and MetabolismProtective factorBreastfeedingCancerBreast NeoplasmsDiseasemedicine.diseaseCohort StudiesBreast FeedingBreast cancerFamily medicineCohortHumansLactationImmunology and AllergyMedicineFemalePreventive MedicinebusinessProspective cohort studyCohort studyEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

Anticoagulation in Cancer Patients with Atrial Fibrillation and Grade 3-4 Thrombocytopenia

2021

Abstract Introduction: Atrial fibrillation (AF) is not uncommon in cancer patients with grade 3-4 thrombocytopenia (platelets <50x10 9/L). The risk of bleeding appears to outweigh the risk of thrombosis in acute leukemia patients. There are no published data regarding management of anticoagulation (AC) and rates of bleeding and thrombosis in other cancer types. Aim: To assess AC management and incidence of bleeding and thrombosis in thrombocytopenic cancer patients with AF. Methods: Single-center retrospective cohort study. The study included adults with active cancer, grade 3-4 thrombocytopenia (platelets <50x10 9/L) and AF with CHA 2DS 2-VASc ≥1, irrespective of AC status pr…

medicine.medical_specialtybusiness.industryInternal medicineImmunologymedicineCardiologyCancerAtrial fibrillationCell BiologyHematologymedicine.diseasebusinessBiochemistryBlood
researchProduct

Association of the rs4567312 variant in the leptin receptor gene with plasma leptin concentrations and lung cancer incidence in the PREDIMED study

2017

medicine.medical_specialtybusiness.industryLeptinIncidence (epidemiology)Hematologymedicine.diseaseLeptin Receptor GenePredimedEndocrinologyOncologyInternal medicineMedicinebusinessLung cancer
researchProduct

Clinical research focused in European adult women with minority diseases: Do we try hard enough?

2021

We analyzed the European countries participation in clinical trials addressing to new drug development focused on rare diseases in women comparing to more prevalent diseases as breast cancer. Participation was not associated with type of healthcare system neither socio-economic features, but it was associated with population size. Protocol ratios focused on breast cancer vs. orphan drugs and rare diseases was 15:1 and 9:1, respectively, mainly focused on ovarian cancer. Protocol number was insufficient to evaluate the success of Regulation (EC) 141/2000, it is necessary to increase the scientific quality and the number of really new molecules.

medicine.medical_specialtybusiness.industryMEDLINEmedicine.diseaseAdult womenClinical trialOrphan drugClinical researchBreast cancerDrug developmentFamily medicineGeneral Health ProfessionsMedicinebusinessOvarian cancer
researchProduct

Co-morbid mental health conditions in cancer patients at working age - prevalence, risk profiles, and care uptake

2013

Summary Objective This study examined the prevalence of mental health conditions in cancer patients, the role of socioeconomic position in relation to that, and the use of professional mental health care. Methods Prospective cohort with measurements at the beginning of inpatient treatment (baseline) and 3, 9, and 15 months after baseline using structured clinical interviews based on DSM-IV, questionnaires, and medical records. Results At baseline, 149 out of 502 cancer patients (30%) were diagnosed with a mental health condition. Prevalence was associated with unemployment (odds ratio [OR] 2.0), fatigue (OR 1.9), and pain (OR 1.7). Of those with mental health conditions, 9% saw a psychother…

medicine.medical_specialtybusiness.industryMedical recordCancerExperimental and Cognitive PsychologyOdds ratiomedicine.diseaseCo morbidMental healthRisk profilePsychiatry and Mental healthOncologyMedicineWorking agebusinessPsychiatryProspective cohort studyPsycho-Oncology
researchProduct

Treatment of Non-Melanoma Skin Cancer with Different Radiation Techniques

2014

ABSTRACT Aim: To compare local control and toxicity in non melanoma skin cancer treated with electrons and Leipzig applicators. Methods: We evaluated 60 patients (pts) with non melanoma skin cancer treated using electrons and Leipzig applicators (microselectron-HDR afterloader). The lesions were: 30 basal cell cancer, 17 squamous cell cancer, 10 basosquamous cell cancer, 1 dermatofibrosarcoma, 1 keloid, 1 histiocytoma fibrosus. Median age was 54 (25-84). The lesions were localized on head and neck, except 1 in the sternum and 1 in posterior part of knee. 49 pts underwent surgery before radiation treatment with negative margin in 38 pts and positive margins in 11. 30 pts were treated with el…

medicine.medical_specialtybusiness.industryMelanomaCancerHematologymedicine.diseaseSurgeryLesionKeloidOncologyMedian follow-upmedicineBasal cell carcinomaRadiologySkin cancermedicine.symptomBolus (digestion)businessAnnals of Oncology
researchProduct

Changes of Hemodynamic Parameters, Pulmonary Gas Exchange, and Extravascular Lung Water During Esophageal Cancer Surgery

1988

Esophagectomy is often connected to postoperative pulmonary complications with a high mortality rate [1, 3,4]. From 1980 to 1985 we treated 19 patients after esophagectomy in our intensive care unit. Nine patients (47%) died of pulmonary complications. From the literature [3] and from our own observations we came to the conclusion that the first pulmonary changes start during the operative procedure.

medicine.medical_specialtybusiness.industryMortality ratemedicine.medical_treatmentPulmonary ComplicationHemodynamicsEsophageal cancermedicine.diseaseIntensive care unitlaw.inventionVagus nerveSurgerymedicine.anatomical_structurelawEsophagectomyAnesthesiaVascular resistanceMedicinebusiness
researchProduct